BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 34843858)

  • 1. Saving time by replacing the standardised two-hour oral glucose tolerance test with a one-hour test: Validation of a new screening algorithm in patients with coronary artery disease from the ESC-EORP EUROASPIRE V registry.
    Ferrannini G; De Bacquer D; Gyberg V; De Backer G; Kotseva K; Mellbin LG; Risebrink R; Tuomilehto J; Wood D; Rydén L
    Diabetes Res Clin Pract; 2022 Jan; 183():109156. PubMed ID: 34843858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Time-saving screening for diabetes in patients with coronary artery disease: a report from EUROASPIRE IV.
    Gyberg V; De Bacquer D; Kotseva K; De Backer G; Schnell O; Tuomilehto J; Wood D; Rydén L
    BMJ Open; 2016 Dec; 6(12):e013835. PubMed ID: 27932342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Report of the Committee on the classification and diagnostic criteria of diabetes mellitus.
    Kuzuya T; Nakagawa S; Satoh J; Kanazawa Y; Iwamoto Y; Kobayashi M; Nanjo K; Sasaki A; Seino Y; Ito C; Shima K; Nonaka K; Kadowaki T;
    Diabetes Res Clin Pract; 2002 Jan; 55(1):65-85. PubMed ID: 11755481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening for dysglycaemia in patients with coronary artery disease as reflected by fasting glucose, oral glucose tolerance test, and HbA1c: a report from EUROASPIRE IV--a survey from the European Society of Cardiology.
    Gyberg V; De Bacquer D; Kotseva K; De Backer G; Schnell O; Sundvall J; Tuomilehto J; Wood D; Rydén L;
    Eur Heart J; 2015 May; 36(19):1171-7. PubMed ID: 25670820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of type 2 diabetes mellitus using fasting plasma glucose and HbA1c levels among individuals with impaired fasting plasma glucose: a cross-sectional study in Thailand.
    Sitasuwan T; Lertwattanarak R
    BMJ Open; 2020 Nov; 10(11):e041269. PubMed ID: 33172945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of oral glucose tolerance testing and HbA1c at 6-14 gestational weeks to predict gestational diabetes mellitus in high-risk women.
    Peng X; Liu M; Gang J; Wang Y; Ma X
    Arch Gynecol Obstet; 2023 May; 307(5):1451-1457. PubMed ID: 35670847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Undetected dysglycaemia common in primary care patients treated for hypertension and/or dyslipidaemia: on the need for a screening strategy in clinical practice. A report from EUROASPIRE IV a registry from the EuroObservational Research Programme of the European Society of Cardiology.
    Shahim B; Gyberg V; De Bacquer D; Kotseva K; De Backer G; Schnell O; Tuomilehto J; Wood D; Rydén L
    Cardiovasc Diabetol; 2018 Jan; 17(1):21. PubMed ID: 29368616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fasting glucose, HbA1c, or oral glucose tolerance testing for the detection of glucose abnormalities in patients with acute coronary syndromes.
    Hage C; Lundman P; Rydén L; Mellbin L
    Eur J Prev Cardiol; 2013 Aug; 20(4):549-54. PubMed ID: 22456695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between fasting plasma glucose and glycosylated hemoglobin: potential for false-positive diagnoses of type 2 diabetes using new diagnostic criteria.
    Davidson MB; Schriger DL; Peters AL; Lorber B
    JAMA; 1999 Apr; 281(13):1203-10. PubMed ID: 10199430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening for diabetes mellitus--a two-step approach in individuals with impaired fasting glucose improves detection of those at risk of complications.
    Tai ES; Lim SC; Tan BY; Chew SK; Heng D; Tan CE
    Diabet Med; 2000 Nov; 17(11):771-5. PubMed ID: 11131101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Editor's Choice- Diagnosis of type 2 diabetes and prediabetes among patients with acute coronary syndromes.
    Bjarnason TA; Kristinsdottir LB; Oskarsdottir ES; Hafthorsson SO; Olafsson I; Lund SH; Andersen K
    Eur Heart J Acute Cardiovasc Care; 2017 Dec; 6(8):744-749. PubMed ID: 27625341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The clinical application of glycosylated hemoglobin A1c and glycated albumin values in cirrhosis patients with hyperglycemia].
    Shao F; Li Q; Jia W
    Zhonghua Nei Ke Za Zhi; 2015 Jun; 54(6):506-10. PubMed ID: 26359011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Prognostic Value of Fasting Plasma Glucose, Two-Hour Postload Glucose, and HbA
    Shahim B; De Bacquer D; De Backer G; Gyberg V; Kotseva K; Mellbin L; Schnell O; Tuomilehto J; Wood D; Rydén L
    Diabetes Care; 2017 Sep; 40(9):1233-1240. PubMed ID: 28637653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Newly diagnosed diabetes based on an oral glucose tolerance test predicts cardiovascular outcomes in patients with coronary artery disease: An observational study.
    Chen WL; Sheu WH; Li YH; Wang JS; Lee WJ; Liang KW; Lee WL; Lee IT
    Medicine (Baltimore); 2022 Jul; 101(28):e29557. PubMed ID: 35839026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlations between A1c, fasting glucose, 2h postload glucose, and β-cell function in the Chinese population.
    Li C; Yang H; Tong G; Shen S; Feng W; Bi Y; Zhu D
    Acta Diabetol; 2014 Aug; 51(4):601-8. PubMed ID: 24595519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined use of fasting plasma glucose and glycated hemoglobin A1c in the screening of diabetes and impaired glucose tolerance.
    Hu Y; Liu W; Chen Y; Zhang M; Wang L; Zhou H; Wu P; Teng X; Dong Y; Zhou Jw; Xu H; Zheng J; Li S; Tao T; Hu Y; Jia Y
    Acta Diabetol; 2010 Sep; 47(3):231-6. PubMed ID: 19760291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of haemoglobin A1c to detect impaired fasting glucose or Type 2 diabetes in a United Kingdom community based population.
    Kumaravel B; Bachmann MO; Murray N; Dhatariya K; Fenech M; John WG; Scarpello TJ; Sampson MJ;
    Diabetes Res Clin Pract; 2012 May; 96(2):211-6. PubMed ID: 22257419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A two-step strategy for identification of high-risk subjects for a clinical trial of prevention of NIDDM.
    Narayan KM; Hanson RL; Pettitt DJ; Bennett PH; Knowler WC
    Diabetes Care; 1996 Sep; 19(9):972-8. PubMed ID: 8875091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HbA1c measurement improves the detection of type 2 diabetes in high-risk individuals with nondiagnostic levels of fasting plasma glucose: the Early Diabetes Intervention Program (EDIP).
    Perry RC; Shankar RR; Fineberg N; McGill J; Baron AD;
    Diabetes Care; 2001 Mar; 24(3):465-71. PubMed ID: 11289469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Performance and costs of multiple screening strategies for type 2 diabetes: two population-based studies in Shanghai, China.
    Li Y; Jiang H; Cheng M; Yao W; Zhang H; Shi Y; Xu W
    BMJ Open Diabetes Res Care; 2020 Aug; 8(1):. PubMed ID: 32816870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.